Search - tctmd.com

Displaying 461 - 480 of 882

Sort: Relevancy | Date

Presentation TCT 2017

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Should Pre-Diabetes Affect Revascularization Decisions?

Presenter: David J. Maron, Alan C. Yeung, Clemens von Birgelen

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Presenter: David J. Maron, Alan C. Yeung, Michael E. Farkouh

November 01, 2017

Presentation TCT 2017

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung

November 01, 2017

Presentation TCT 2017

Is There a Preferred Stent for the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Upendra Kaul

November 01, 2017

Presentation TCT 2017

When Should PCI Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Sripal Bangalore

November 01, 2017

Presentation TCT 2017

Should a Hybrid Revascularization Strategy for Left Main Disease Be Considered?

Presenter: James B. Hermiller Jr., John D. Puskas

November 01, 2017

Presentation TCT 2017

When Should CABG Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Jack Boyd

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Presentation TCT 2017

Debate: EXCEL and NOBLE Prove That PCI Is Still Far From Being an Acceptable Alternative to CABG for Left Main Revascularization, With the Exception of a Small Proportion of Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, John D. Puskas

October 31, 2017

Presentation TCT 2017

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, Marco V. Wainstein

October 31, 2017

Presentation TCT 2017

Left Main Case(s) #7: Rationale and Feasibility of Bioresorbable Scaffolds

Presenter: Kenneth Chin, Nicholas J. Lembo, Bernardo Cortese

October 31, 2017

Presentation TCT 2017

Left Main Case(s) #3: My Best DK-Crush Cases

Presenter: Kenneth Chin, Nicholas J. Lembo, James B. Hermiller Jr.

October 31, 2017

Presentation TCT 2017

Left Main Case(s) #5: A Complex Left Main Trifurcation

Presenter: Kenneth Chin, Nicholas J. Lembo, Vinay K. Bahl

October 31, 2017

Presentation TCT 2017

Left Main Case(s) #4: My Best TAP Cases

Presenter: Kenneth Chin, Nicholas J. Lembo, Yves R. Louvard

October 31, 2017

Presentation TCT 2017

Left Main Case(s) #2: I Did Not Imagine This Case Would Require Two Stents!

Presenter: Kenneth Chin, Nicholas J. Lembo, Goran Stankovic

October 31, 2017

Presentation TCT 2017

Left Main Case(s) #1: I Did Not Imagine This Case Would Require One Stent Only!

Presenter: Kenneth Chin, Nicholas J. Lembo, Philippe Garot

October 31, 2017

Presentation TCT 2017

Left Main PCI in the Emergent Setting (STEMI, Catheter-Induced Dissection, Coronary Obstruction During TAVR, and More)

Presenter: David Hildick-Smith, Jeffrey W. Moses, Giovanni GB Pedrazzini

October 31, 2017

Presentation TCT 2017

Mechanical Hemodynamic Support Should be Established Before Revascularization: Results From the US Impella Registry

Presenter: Michael Mooney, Holger Thiele, Brian P O'Neill

October 31, 2017

Presentation TCT 2017

Has DK Crush Emerged As the New Standard for Two-Stent Left Main PCI? Results From the DKCRUSH-III and DKCRUSH-V Trials

Presenter: David Hildick-Smith, Jeffrey W. Moses, Zhen Ge

October 31, 2017

Advertisement

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Should Pre-Diabetes Affect Revascularization Decisions?

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Is There a Preferred Stent for the Diabetic Patient?

When Should PCI Be Preferred in the Diabetic Patient?

Should a Hybrid Revascularization Strategy for Left Main Disease Be Considered?

When Should CABG Be Preferred in the Diabetic Patient?

Live From Denver: TCT 2017, Day Three

Debate: EXCEL and NOBLE Prove That PCI Is Still Far From Being an Acceptable Alternative to CABG for Left Main Revascularization, With the Exception of a Small Proportion of Patients!

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Left Main Case(s) #7: Rationale and Feasibility of Bioresorbable Scaffolds

Left Main Case(s) #3: My Best DK-Crush Cases

Left Main Case(s) #5: A Complex Left Main Trifurcation

Left Main Case(s) #4: My Best TAP Cases

Left Main Case(s) #2: I Did Not Imagine This Case Would Require Two Stents!

Left Main Case(s) #1: I Did Not Imagine This Case Would Require One Stent Only!

Left Main PCI in the Emergent Setting (STEMI, Catheter-Induced Dissection, Coronary Obstruction During TAVR, and More)

Mechanical Hemodynamic Support Should be Established Before Revascularization: Results From the US Impella Registry

Has DK Crush Emerged As the New Standard for Two-Stent Left Main PCI? Results From the DKCRUSH-III and DKCRUSH-V Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content